GlassScriptPhysician profile
Murad Adnan Aburajab
NPI 1376750745
$5,866.81
in general payments reported to CMS, 2019-2025
21 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $1,109 · 2021: $284 · 2022: $1,256 · 2023: $755 · 2024: $753 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,454 · Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,453.73 |
| Food and Beverage | $1,225.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,115.35 | 2019-2025 | Orise, Exalt Model D, Captivator II |
| Endogastric Solutions, INC | $1,008.09 | 2020 | |
| Olympus Corporation of The Americas | $818.28 | 2023-2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Medtronic, INC. | $320.82 | 2023-2024 | Endoflip, Progrip |
| Lumendi LLC | $224.48 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $197.45 | 2019 | |
| Cook Medical LLC | $177.81 | 2021-2022 | |
| Genzyme Corporation | $131.95 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $129.00 | 2025 | Dupixent |
| Janssen Biotech, INC. | $124.25 | 2025 | Tremfya |
| Covidien LP | $112.50 | 2019 | |
| Terumo Medical Corporation | $107.45 | 2024 | Azur Cx Detachable |
| Ambu INC. | $100.50 | 2020 | |
| Conmed Corporation | $99.51 | 2021 | |
| Stryker Corporation | $41.53 | 2023-2024 | Neptune |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $39.67 | 2019 | |
| Abbvie INC. | $37.02 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.14 | 2019 | |
| Ironwood Pharmaceuticals, INC | $21.03 | 2024 | |
| Gilead Sciences, INC. | $15.09 | 2019 | |
| Pfizer INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murad Aburajab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.